|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|
| Revenue | |||
| Cost of sales | |||
| Gross profit | |||
| Research and development expenses | |||
| General and administrative expenses | |||
| Selling expenses | |||
| Other income | |||
| Other expenses | |||
| Operating loss | |||
| Finance income | |||
| Finance expenses | |||
| Financial result | |||
| Share of loss in a joint venture / associate | |||
| Loss before income tax | |||
| Income tax (expense) / benefit | |||
| Net loss for the year | |||
| Other comprehensive (loss) / income | |||
| Other comprehensive (loss) / income that may be reclassified to profit or loss | |||
| Exchange differences on translation of foreign business units | |||
| Items that will not be subsequently reclassified to profit or loss | |||
| Remeasurement of defined pension benefit obligation | |||
| Other comprehensive (loss) / income | |||
| Total consolidated comprehensive loss for the year | |||
| Loss per share basic (in Euro per share) | |||
| Loss per share diluted (in Euro per share) |
Loading...